Analyst Ratings for Obagi Medical Products (OMPI) [Neutrals]
OMPI Rating Summary
OMPI Price Target Summary
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$18.92 (-21.1%)
Avg. $ Target:
$18.92 (-21.1%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/27/2013 | Roth Capital | Downgrade | Neutral (Buy) |
19.75 (17.00) |
19.71 | 23.98 | 21.66% | Details |
| 3/21/2013 | Cantor Fitzgerald » Updated 4/2/2013 |
Downgrade | Hold (Buy) |
22.00 (19.75) |
19.73 | 23.98 | 21.54% | Details |
| 5/9/2011 | Duncan Williams » Updated 7/6/2011 |
Downgrade | Hold (N/A) |
N/A (N/A) |
9.80 | 23.98 | 144.69% | Details |
| 5/6/2011 | Needham & Company » Updated 8/3/2012 |
Downgrade | Hold (N/A) |
N/A (N/A) |
8.90 | 23.98 | 169.44% | Details |
| 5/6/2011 | Baird | Downgrade | Neutral (N/A) |
N/A (N/A) |
8.90 | 23.98 | 169.44% | Details |
